-
Uncategorized2 months ago
GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
-
Uncategorized2 months ago
Life on Mars? Tiny cells just survived shock waves and toxic soil
Mars may be hostile, but it might not be entirely unlivable. In lab experiments, yeast cells survived simulated Martian shock waves and toxic perchlorate salts—two major...
-
Uncategorized2 months agoOpinion: Sports betting is creating a twofold public health crisis for some young men
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Isaac Rose-Berman. Be sure to sign up for the weekly “First Opinion...
-
Uncategorized2 months agoOpinion: What STAT readers think about nutrition education in med school
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and...
-
Uncategorized2 months ago
More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
-
Uncategorized2 months ago
A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension
Post Content
-
Uncategorized2 months ago
Epigenetics at Birth Links Microbiome to Neurodevelopment, Potentially ASD and ADHD
The results of a study headed by researchers at Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, indicate that the gut...
-
Uncategorized2 months ago
Plan for remade ACIP panel adds focus on vaccine safety, matching Kennedy’s push
Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel will...
-
Uncategorized2 months ago
Bayer pharma executive predicts US-Europe price spreads will narrow
The price differential between the US and other countries “will be significantly narrower or smaller” going forward because of pressure from the Trump administration’s “most favored...
-
Uncategorized2 months ago
FDA rejects Replimune cancer therapy, saying company didn’t resolve trial doubts
The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma. The Massachusetts-based drugmaker had been pushing for a reconsideration by the agency...
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
